SWTX

Springworks Therapeutics Inc

A biopharmaceutical company that develops and sells targeted medicines for rare diseases and cancer. Its approved drugs include OGSIVEO, the first FDA-approved therapy for desmoid tumors, and GOMEKLI, a treatment for a form of neurofibromatosis affecting both adults and children. SpringWorks was founded in 2017 as a spinoff from Pfizer, created to "spring" promising drug candidates that the pharma giant had shelved back to life — hence the name.

No 8-K or 6-K filings recorded.